UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045445
Receipt number R000051881
Scientific Title Screening for disease progression by measuring lower limb circumference in diabetic patients.
Date of disclosure of the study information 2021/09/10
Last modified on 2021/09/10 14:11:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Screening for disease progression by measuring lower limb circumference in diabetic patients.

Acronym

Screening for disease progression by measuring lower limb circumference in diabetic patients.

Scientific Title

Screening for disease progression by measuring lower limb circumference in diabetic patients.

Scientific Title:Acronym

Screening for disease progression by measuring lower limb circumference in diabetic patients.

Region

Japan


Condition

Condition

diabetes mellitus
Arteriosclerosis

Classification by specialty

Cardiology Endocrinology and Metabolism Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study was to clarify the usefulness of the evaluation of the maximum circumference of the thigh and lower leg in screening for disease progression in patients with diabetes mellitus (DM).

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Primary endpoint: Association between femoral leg circumference ratio and DM pathological parameters in DM patients.
Factor analysis was performed using regression analysis with the femoral-femoral circumference ratio as the dependent variable.
Thigh-to-lower leg circumference ratio is the ratio of lower leg circumference to thigh circumference.

Key secondary outcomes

Secondary endpoints: Change from baseline in lower extremity circumference at 12 to 15 months.
Basic information: sex, age, disease, medication status.
Body composition (body weight, body water content, muscle mass, body fat content, body fat percentage, basal metabolic rate, visceral fat level, BMI)
Vascular index: ABI, PWV
Muscle output: knee extensor strength, ankle plantar flexor strength
Blood test data: HbA1C
From the above, DM-related items are defined as HbA1c, DM duration, PWV, and ABI. The methods of measurement are described in the following sections.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Eligible patients are outpatients undergoing treatment for type II DM.

Key exclusion criteria

Patients with musculoskeletal disorders of the lower extremities (not excluded if there is no swelling in the lower extremities), amputees, patients with obvious paralysis due to central nervous system disorders, patients with arteriosclerosis obliterans, patients with malignant neoplasms, pregnant women or women suspected of pregnancy, and patients with intracorporeal devices such as cardiac pacemakers.

Target sample size

150


Research contact person

Name of lead principal investigator

1st name TOMOKI
Middle name
Last name furuya

Organization

Dokkyo Medical University Nikko Medical Center,

Division name

Department of Cardiovascular Medicine and Nephrology,

Zip code

321-2593

Address

632 Takatoku, Nikko-city, Tochigi, Japan

TEL

0288-76-1515

Email

furuya19870818@gmail.com


Public contact

Name of contact person

1st name TOMOKI
Middle name
Last name furuya

Organization

Dokkyo Medical University Nikko Medical Center,

Division name

Department of Cardiovascular Medicine and Nephrology,

Zip code

321-2593

Address

632 Takatoku, Nikko-city, Tochigi, Japan

TEL

0288-76-1515

Homepage URL


Email

furuya19870818@gmail.com


Sponsor or person

Institute

Dokkyo Medical University Nikko Medical Center,

Institute

Department

Personal name



Funding Source

Organization

Japan Science and Technology Agency (JST)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Dokkyo Medical University Nikko Medical Center,

Address

632 Takatoku, Nikko-city, Tochigi, Japan

Tel

0288-76-1515

Email

furuya19870818@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 09 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

128

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2021 Year 09 Month 10 Day

Date of IRB

2020 Year 07 Month 27 Day

Anticipated trial start date

2021 Year 09 Month 10 Day

Last follow-up date

2021 Year 09 Month 10 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

unspecified


Management information

Registered date

2021 Year 09 Month 10 Day

Last modified on

2021 Year 09 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051881